|
Eduardo Beruff is the founding President of ITA Partners, responsible for the company’s direction, management, and long-term growth. Mr. Beruff has 30 years of experience, primarily in health care, as a corporate leader, entrepreneur, and management consultant. Throughout his career, he has helped companies to formulate strategy, enhance operational performance, and generate superior financial results.
Selected accomplishments include:
Since 1998, Mr. Beruff has worked closely with the leadership of the world’s largest group of clinical researchers in cancer. He helped lead the strategic planning process for the newly created Coalition of Cancer Cooperative Groups and was instrumental in the development and implementation of strategies designed to accelerate drug development in cancer therapy.
As CEO throughout the Americas for SICPA Group, a $1 billion, global, privately held, specialty chemical firm, Mr. Beruff secured U.S. government contracts in excess of $250 million, the largest in company history. In addition to leading the company's core business to new levels of profitability, he identified new strategic markets and launched a fast-growing multi-million-dollar division.
For pharmaceutical giant SmithKline Beecham (now GlaxoSmithKline), Mr. Beruff held a variety of senior-level positions in finance, marketing, management, and corporate planning. He grew the U.S.-based vaccine business from start-up to a $400 million division in three years. Overseas, he guided SmithKline companies to positions of market leadership and higher profitability.
Mr. Beruff also served on the board of directors and chaired the audit committee for the Unimark Group, at the time a $100 million revenue NASDAQ company. He helped to engineer the strategy that led to the eventual privatization of the company, generating significant value to shareholders.
Mr. Beruff is a graduate of The Wharton School (MBA) and Georgetown University (magna cum laude). | 